Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
5.88
+0.02 (0.34%)
Oct 29, 2025, 4:52 PM CET

Hyloris Pharmaceuticals Revenue

Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.

Revenue (ttm)
8.46M
Revenue Growth
+30.42%
P/S Ratio
19.40
Revenue / Employee
169.18K
Employees
49
Market Cap
164.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.76M6.00M159.64%
Dec 31, 20233.76M1.37M57.48%
Dec 31, 20222.39M-709.00K-22.90%
Dec 31, 20213.10M2.92M1,669.14%
Dec 31, 2020175.00K84.00K92.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition